Tag: invasive aspergillosis

1. Posaconazole  was non-inferior to voriconazole with respect to all-cause mortality at day 42 (15% vs. 21%, respectively). 2. Incidence of treatment-related adverse events was lower for posaconazole than voriconazole.  Evidence Rating Level: 2 (Good)  Study Rundown: Invasive aspergillosis (IA) is a life-threatening infection that commonly occurs in patients with immunosuppression. Currently, voriconazole serves as...
1. Posaconazole  was non-inferior to voriconazole with respect to all-cause mortality at day 42 (15% vs. 21%, respectively). 2. Incidence of treatment-related adverse events was lower for posaconazole than voriconazole.  Evidence Rating Level: 2 (Good)  Study Rundown: Invasive aspergillosis (IA) is a life-threatening infection that commonly occurs in patients with immunosuppression. Currently,...